23andMe
our lead program was identified with and applied to our proprietary i genetic signature | 23andMe
Company
Deck Type
Sector
Industry
Deck date
February 2021
Slide
33 of 47
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Presentation
April 2023
our i programs were identified with and applied to our proprietary i genetic signature | 23andMe
Investor Presentation
August 2022
our i programs were identified with and applied to our proprietary i genetic signature | 23andMe
Investor Presentation
February 2022
our lead program was identified with and applied to our proprietary i genetic signature | 23andMe
Related slides by other companies
Ginkgo
Investor Conference
June 2021
each new cell program can accelerate adoption within new markets and lead to further sales with existing customers | Ginkgo
Ginkgo
Investor Conference
June 2021
each new cell program can accelerate adoption within new markets and lead to further sales with existing customers | Ginkgo
Ginkgo
SPAC
May 2021
each new cell program can accelerate adoption within new markets and lead to further sales with existing customers | Ginkgo
Adagio Therapeutics
Investor Conference
January 2023
overview of | Adagio Therapeutics
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights